Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes Increased Immunopathology following Leishmania major Infection

PLoS Pathogens

Volumn 10, Issue 2, 2014, Pages

  Crosby, Erika J ^a   Goldschmidt, Michael H ^a   Wherry, E John ^b   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 4; NATURAL KILLER CELL RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RESPONSE; DEGRANULATION; EAR CARTILAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; LEISHMANIASIS; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; ULCER; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84897681023     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003970     Document Type: Article

References (78)

1. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL, (2010) Type I interferons regulate cytolytic activity of memory CD8+ T cells in the lung airways during respiratory virus challenge. Immunity 33: 96-105.
2. Berg RE, Crossley E, Murray S, Forman J, (2003) Memory CD8+ T cells provide innate immune protection against listeria monocytogenes in the absence of cognate antigen. J Exp Med 198: 1583-1593.
3. Polley R, Sanos SL, Prickett S, Haque A, Kaye PM, (2005) Chronic Leishmania donovani infection promotes bystander CD8+ cell expansion and heterologous immunity. Infect Immun 73: 7996-8001.
4. Soudja S, Ruiz A, Marie J, Lauvau G, (2012) Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549-562.
5. Chu T, Tyznik A, Roepke S, Berkley A, Woodward-Davis A, et al. (2013) Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep 3: 701-708.
6. Freeman BE, Hammarlund E, Raué H, Slifka MK, (2012) Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci 109: 9971-9976.
7. Marshall HD, Prince AL, Berg LJ, Welsh RM, (2010) IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol 185: 1419-1428.
8. Raué H, Beadling C, Haun J, Slifka M, (2013) Cytokine-mediated programmed proliferation of virus-specific CD8+ memory T cells. Immunity 38: 131-139.
9. Raué H, Brien JD, Hammarlund E, Slifka MK, (2004) Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol 173: 6873-6881.
10. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
11. Sacks D, Noben-Trauth N, (2002) The immunology of susceptibility and resistance to leishmania major in mice. Nat Rev Immunol 2: 845-858.
12. Kaye P, Scott P, (2011) Leishmaniasis: Complexity at the host-pathogen interface. Nat Rev Micro 9: 604-615.
13. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, et al. (2002) CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with leishmania major. J Immunol 168: 3992-4000.
14. Uzonna JE, Joyce KL, Scott P, (2004) Low dose leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon γ-producing CD8+ T cells. J Exp Med 199: 1559-1566.
15. Pearson RD, Sousa AdQ, (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22: 1-11.
16. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
17. Lessa MM, Lessa HA, Castro TWN, Oliveira A, Scherifer A, et al. (2007) Mucosal leishmaniasis: Epidemiological and clinical aspects. Braz J Otorhinolaryngol 73: 843-847.
18. Bacellar O, Faria D, Nascimento M, Cardoso TM, Gollob KJ, et al. (2009) Interleukin 17 production among patients with american cutaneous leishmaniasis. J Infect Dis 200: 75-78.
19. Boaventura VS, Santos CS, Cardoso CR, de Andrade J, Dos Santos WLC, et al. (2010) Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 40: 2830-2836.
20. Oliveira F, Bafica A, Rosato AB, Favali CBF, Costa JM, et al. (2011) Lesion size correlates with leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg 85: 70-73.
21. Oliveira CF, Manzoni-de-Almeida D, Mello PS, Natale CC, Santiago HdC, et al. (2012) Characterization of chronic cutaneous lesions from TNF-receptor-1-deficient mice infected by Leishmania major. Clin Dev Immunol pp. 1-12.
22. Gonzalez-Lombana C, Gimblet C, Bacellar O, Oliveira WW, Passos S, et al. (2013) IL-17 mediates immunopathology in the absence of IL-10 FollowingLeishmania majorInfection. PLoS Pathog 9: 1-13.
23. Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M, (1997) Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 159: 4467-4473.
24. Faria DR, Souza PEA, Duraes FV, Carvalho EM, Gollob KJ, et al. (2009) Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 31: 432-439.
25. Santos CdS, Boaventura V, Cardoso CR, Tavares N, Lordelo MJ, et al. (2013) CD8+Granzyme B+ mediated tissue injury versus CD4+IFNg+ mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 133: 1533-1540.
26. Novias F, Carvalho LP, Graff JW, Beiting DP, Ruthel G, et al. (2013) Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog 9: e1003504.
27. Ely KH, Cauley LS, Roberts AD, Brennan JW, Cookenham T, et al. (2003) Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J Immunol 170: 1423-1429.
28. Butcher EC, Picker LJ, (1996) Lymphocyte homing and homeostasis. Science 272: 60-67.
29. Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, et al. (2004) Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 172: 4875-4882.
30. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, et al. (2009) Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196-199.
31. Cornberg M, Clute SC, Watkin LB, Saccoccio FM, Kim S, et al. (2010) CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. Journal of Immunology 184: 2825-2838.
32. Chen AT, Cornberg M, Gras S, Guillonneau C, Rossjohn J, et al. (2012) Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. Plos Pathogens 8: e1002633.
33. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, et al. (2002) T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3: 627-634.
34. Wlodarczyk MF, Kraft AR, Chen HD, Kenney LL, Selin LK, (2013) Anti-IFN-gamma and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells. Journal of Immunology 190: 2736-2746.
35. Nie S, Lin S, Kim S, Welsh RM, Selin LK, (2010) Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 176: 2107-2112.
36. Overath P, Harbecke D, (1993) Course of leishmania infection in beta-2-microglobulin-deficient mice. Immunol Lett 37: 13-17.
37. Wang ZE, Reiner SL, Hatam F, Heinzel FP, Bouvier J, et al. (1993) Targeted activation of CD8 cells and infection of beta-2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J Immunol 151: 2077-2086.
38. Huber M, Timms E, Mak T, Rollinghoff M, Lohoff M, (1998) Effective and long-lasting immunity against the parasite leishmania major in CD8-deficient mice. Infect Immun 66: 3968-3970.
39. Groh V, Wu J, Yee C, Spies T, (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
40. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, et al. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29.
41. Verneris MR, Karami M, Baker J, Jayaswal A, Negrin RS, (2004) Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 103: 3065-3072.
42. Tietze JK, Wilkins DEC, Sckisel GD, Bouchlaka MN, Alderson KL, et al. (2012) Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood 119: 3073-3083.
43. Champsaur M, Lanier LL, (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235: 267-285.
44. Zafirova B, Wensveen FM, Gulin M, Polic B, (2011) Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Life Sci 68: 3519-3529.
45. Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, et al. (2004) The VITAL assay: A versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25-40.
46. Cerwenka A, Baron J, Lanier L, (2001) Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 98: 11521-11526.
47. Peltola VT, McCullers JA, (2004) Respiratory viruses predisposing to bacterial infections: Role of neuraminidase. Pediatr Infect Dis J 23: S87-S96.
48. Beadling C, Slifka MK, (2004) How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis 17: 185-191.
49. Jones WT, Menna JH, Wennerstrom DE, (1983) Lethal synergism induced in mice by influenza type-a virus and type-ia group-B streptococci. Infect Immun 41: 618-623.
50. Okamoto S, Kawabata S, Nakagawa I, Okuno Y, Goto T, et al. (2003) Influenza A virus-infected hosts boost an invasive type of streptococcus pyogenes infection in mice. J Virol 77: 4104-4112.
51. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, et al. (2013) Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340: 1230-1234.
52. Stelekati E, Wherry E, (2012) Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe 12: 458-469.
53. La Flamme A, Scott P, Pearce E, (2002) Schistosomiasis delays lesion resolution during leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol 24: 339-345.
54. Andreani G, Lodge R, Richard D, Tremblay MJ, (2012) Mechanisms of interaction between protozoan parasites and HIV. Curr Opin HIV AIDS 7: 276-282.
55. Tough DF, Borrow P, Sprent J, (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950.
56. Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel R, (1997) Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 185: 1241-1251.
57. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, et al. (1998) Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
58. Masopust D, Murali-Krishna K, Ahmed R, (2007) Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: It is even bigger than we thought. J Virol 81: 2002-2011.
59. Selin LK, Varga SM, Wong IC, Welsh RM, (1998) Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 188: 1705-1715.
60. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, et al. (2001) Memory CD8(+)T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2: 1067-1076.
61. Kim S, Brehm M, Welsh R, Selin L, (2002) Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol 169: 90-98.
62. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK, (2003) Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 163: 1341-1355.
63. Welsh RM, Selin LK, Szomolanyi-Tsuda E, (2004) Immunological memory to viral infections. Annu Rev Immunol 22: 711-743.
64. Mathurin KS, Martens GW, Kornfeld H, Welsh RM, (2009) CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 83: 3528-3539.
65. Kohlmeier JE, Miller SC, Woodland DL, (2007) Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol 178: 4721-4725.
66. Kim S, Cornberg M, Wang XZ, Chen HD, Selin LK, et al. (2005) Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 201: 523-533.
67. Varadarajan N, Julg B, Yamanaka YJ, Chen H, Ogunniyi AO, et al. (2011) A high-throughput single-cell analysis of human CD8(+) T cell functions reveals discordance for cytokine secretion and cytolysis. J Clin Invest 121: 4322-4331.
68. Raué H, Beadling C, Haun J, Slifka M, (2013) Cytokine-mediated programmed proliferation of virus-specific CD8+ memory T cells. Immunity 38: 131-139.
69. Narni-Mancinelli E, Campisi L, Bassand D, Cazareth J, Gounon P, et al. (2007) Memory CD8(+) T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. J Exp Med 204: 2075-2087.
70. Schenkel JM, Fraser KA, Vezys V, Masopust D, (2013) Sensing and alarm function of resident memory CD8+ T cells. Nat Immunol 14: 509-513.
71. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
72. Ortega C, Fernandez-A S, Carrillo JM, Romero P, Molina IJ, et al. (2009) IL-17-producing CD8(+) T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86: 435-443.
73. Res PCM, Piskin G, de Boer OJ, van der Loos CM, Teeling P, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. Plos One 5: 1-11.
74. Da-Cruz AM, Oliveira-Neto MP, Bertho AL, Mendes-Aguiar CO, Coutinho SG, (2010) T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions. J Invest Dermatol 130: 1329-1336.
75. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM, (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
76. Prickett SP, Gray PM, Colpitts SL, Scott P, Kaye PM, et al. (2006) In vivo recognition of ovalbumin expressed by transgenic leishmania is determined by its subcellular localization. J Immunol 176: 4826-4833.
77. Späth GF, Beverley SM, (2001) A lipophosphoglycan-independent method for isolation of infective leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
78. Scott P, Artis D, Uzonna J, Zaph C, (2004) The development of effector and memory T cells in cutaneous leishmaniasis: The implications for vaccine development. Immunol Rev 201: 318-338.